GACM
MDCO

Green Arrow Capital Management’s Medicines Co MDCO Stock Holding History

Green Arrow Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-125,000
Closed -$3.85M – 319
2013
Q2 		$3.85M Buy
+125,000
New +$4.18M 0.31% 106

Other funds holding MDCO

SAC
Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Green Arrow Capital Management's MDCO Position: Q3 2013 in Review

Green Arrow Capital Management sold out of Medicines Co (MDCO) in Q3 2013, closing a stake of 125,000 shares — an estimated $3.85M sold.

Green Arrow Capital Management first reported a position in MDCO in Q2 2013 and held it in 1 quarter. The position peaked at $3.85M in Q2 2013. 172 funds tracked by Wall St. Rank hold MDCO as of Q3 2013.

  • Green Arrow Capital Management reported no remaining Medicines Co position as of Q3 2013 after selling out during the quarter.
  • Green Arrow Capital Management sold 125,000 Medicines Co shares in Q3 2013, an estimated $3.85M.
  • Green Arrow Capital Management first reported a position in Medicines Co in Q2 2013 and held it in 1 quarter.
  • Green Arrow Capital Management's Medicines Co position peaked at $3.85M in Q2 2013.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q3 2013.

Based on Green Arrow Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.